- advertisement -

Promisind developments by Kinexum & DiaKine

Discussion in 'Research' started by Pavlos, May 14, 2008.

Tags:
  1. Pavlos

    Pavlos Approved members

    Joined:
    Nov 28, 2007
    Messages:
    458
  2. Jeff

    Jeff Founder, CWD

    Joined:
    Jun 1, 1995
    Messages:
    1,548
    Interesting to see further work on INGAP. There was a lot of interest several years ago, including Procter & Gamble getting involved, but I haven't heard anything about it in a long time. P&G divested themselves of it.
     
  3. DadCares

    DadCares Approved members

    Joined:
    Apr 19, 2006
    Messages:
    321
    This article refers to a phase 2 trial! Does anyone have the results from the phase 1 trial?

    I knew Dr. Nadler was working with Lisofylline (LSF) to halt the autoimmune attack. In the recent past he was working with a 2nd drug exendin-4 to promote the growth of new pancreatic cells. This article refers to the 2nd therapy being "Islet neogenesis associated protein (INGAP)" Does anyone know if INGAP is different than exendin-4?
     

Share This Page

- advertisement -

  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice